Gene delivery and gene therapy with herpes simplex virus-based vectors (Q34179305)

31 July 2017

1 reference

title

Gene delivery and gene therapy with herpes simplex virus-based vectors (English)

1 reference

31 July 2017

0 references

0 references

Latchman DS

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

264

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

1-9

1 reference

Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Over-expression of heat shock protein 70 protects neuronal cells against both thermal and ischaemic stress but with different efficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Heat shock proteins delivered with a virus vector can protect cardiac cells against apoptosis as well as against thermal or hypoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene Transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Gene transfer to neurons using herpes simplex virus-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Prospects for gene therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Gene therapy scores against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Viral vectors in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Long-term promoter activity during herpes simplex virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Pathways of viral gene expression during acute neuronal infection with HSV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Decreased reporter gene expression during latent infection with HSV LAT promoter constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Human gene therapy comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Fetal nigral transplantation as a therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

An inquiry into the mechanisms of herpes simplex virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-1119%2801%2900322-5

7 January 2021

10.1016/S0378-1119(01)00322-5

Identifiers

DOI

1 reference

31 July 2017

1 reference